Oklahoma 2022 Regular Session

Oklahoma Senate Bill SB136 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
	3	+	SB136 HFLR Page 1
	4	+	BOLD FACE denotes Committee Amendments. 1
	5	+	2
	6	+	3
	7	+	4
	8	+	5
	9	+	6
	10	+	7
	11	+	8
	12	+	9
	13	+	10
	14	+	11
	15	+	12
	16	+	13
	17	+	14
	18	+	15
	19	+	16
	20	+	17
	21	+	18
	22	+	19
	23	+	20
	24	+	21
	25	+	22
	26	+	23
	27	+	24
3	28
4		-	An Act
5		-	ENROLLED SENATE
	29	+	HOUSE OF REPRESENTATIVES - FLOOR VERSION
	30	+
	31	+	STATE OF OKLAHOMA
	32	+
	33	+	1st Session of the 58th Legislature (2021)
	34	+
	35	+	ENGROSSED SENATE
6	36		BILL NO. 136 By: Simpson of the Senate
7	37
8	38		and
9	39
10	40		Roe of the House
11	41
12	42
13	43
14	44
15	45		An Act relating to breast and cervical cancer;
16	46		amending 63 O.S. 2011, Section 1-556, as amended by
17	47		Section 55, Chapter 229, O.S.L. 2013 (63 O.S. Supp.
18	48		2020, Section 1-556), which relates to annual report;
19	49		modifying time period of report; modifying criteria;
20	50		updating statutory references and language; and
21	51		providing an effective date.
22	52
23	53
24	54
25	55
26	56
27		-	SUBJECT: Breast and cervical cance r
28		-
29	57		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
30		-
31	58		SECTION 1. AMENDATORY 63 O.S. 2011, Section 1 -556, as
32	59		amended by Section 55, Chapter 229, O.S.L. 2013 (63 O.S. Supp. 2020,
33	60		Section 1-556), is amended to re ad as follows:
34		-
35	61		Section 1-556. A. The State Department of Health, giving
36	62		consideration to the recommendations of the Advancement of Wellness
37	63		Advisory Council created in Section 44 of this act Section 1-103a.1
38	64		of this title, shall be responsible for evalua ting and reporting to
39	65		the Governor and the State Commissioner of Health regarding
	66	+
	67	+	SB136 HFLR Page 2
	68	+	BOLD FACE denotes Committee Amendments. 1
	69	+	2
	70	+	3
	71	+	4
	72	+	5
	73	+	6
	74	+	7
	75	+	8
	76	+	9
	77	+	10
	78	+	11
	79	+	12
	80	+	13
	81	+	14
	82	+	15
	83	+	16
	84	+	17
	85	+	18
	86	+	19
	87	+	20
	88	+	21
	89	+	22
	90	+	23
	91	+	24
	92	+
40	93		contracting for statewide services or issues related to breast
41	94		cancer including, but not limited to:
42		-
43	95		1. Mammography and pap smear screening of women for breast and
44	96		cervical cancer as an early detection health care measure , provided
45	97		by facilities which are accredited by national organizations that
46		-
47		-	ENR. S. B. NO. 136 Page 2
48	98		have formed coalitions to issue national cancer screening
49	99		guidelines;
50		-
51	100		2. Medical referral of screened persons with abnormal breast
52	101		findings and, to the extent practical, for additional services or
53	102		assistance for such persons;
54		-
55	103		3. Education and training programs for health care
56	104		professionals to improve methods for the detection and control of
57	105		breast and cervical cancer, and to improve communication with breast
58	106		and cervical cancer patients after diagnosis;
59		-
60	107		4. Annual public education and awareness campaigns to improve
61	108		the knowledge and health care practices of all Oklahomans with
62	109		respect to breast and cervical cancer;
63		-
64	110		5. Epidemiological trend studies utilizing the data from the
65	111		Oklahoma Central Cancer Registry for incidence, prevalence and
66	112		survival of breast and cervical cancer victims; and
67		-
68	113		6. Outreach to groups with high proportions of uninsured and
69	114		underinsured women.
70		-
71	115		B. The evaluative efforts of the Advisory Committee with
72	116		respect to contracts for services specified in subsection A of this
	117	+
	118	+	SB136 HFLR Page 3
	119	+	BOLD FACE denotes Committee Amendments. 1
	120	+	2
	121	+	3
	122	+	4
	123	+	5
	124	+	6
	125	+	7
	126	+	8
	127	+	9
	128	+	10
	129	+	11
	130	+	12
	131	+	13
	132	+	14
	133	+	15
	134	+	16
	135	+	17
	136	+	18
	137	+	19
	138	+	20
	139	+	21
	140	+	22
	141	+	23
	142	+	24
	143	+
73	144		section shall provide appropriate oversight and requirements that
74	145		result in:
75		-
76	146		1. Enhanced quality control standards within facilities which
77	147		perform diagnostic cancer screening for breast and cervical cancer;
78	148		and
79		-
80	149		2. Establishment of a fee schedule for breast and cervical
81	150		cancer screening and diagnosis that complies with accepted
82	151		Medicare/Medicaid rates and that incorporates a sliding fee payment
83	152		system to encourage self -responsibility.
84		-
85	153		C. The State Department of Health, giving consideration to the
86	154		recommendations of the Advancement of Wellness Advisory Council
87	155		created in Section 44 of this act Section 1-103a.1 of this title ,
88	156		shall report annually to the Governor, the Speaker of the House of
89	157		Representatives, the President Pro Tempore of the Senate, and the
90		-
91		-	ENR. S. B. NO. 136 Page 3
92	158		State Board Commissioner of Health by October 1 of each year every
93	159		fifth year, beginning on October 1, 2021 , activities completed
94	160		pursuant to the Oklahoma Breast and Cervical Cancer Act during the
95	161		prior five (5) fiscal year, years including a report of the funding
96	162		for revolving funds expended on related activities. The report
97	163		shall may identify populations at highest risk for breast or
98	164		cervical cancer, priority strategies, and emerging technologies ,
99	165		including newly introduced therapies and preventive vaccines that
100	166		are effective in preventing and controlling the risk of breast and
101	167		cervical cancer, and any recommendations for additional funding, if
	168	+
	169	+	SB136 HFLR Page 4
	170	+	BOLD FACE denotes Committee Amendments. 1
	171	+	2
	172	+	3
	173	+	4
	174	+	5
	175	+	6
	176	+	7
	177	+	8
	178	+	9
	179	+	10
	180	+	11
	181	+	12
	182	+	13
	183	+	14
	184	+	15
	185	+	16
	186	+	17
	187	+	18
	188	+	19
	189	+	20
	190	+	21
	191	+	22
	192	+	23
	193	+	24
	194	+
102	195		necessary, to provide screenings and treatment for breast and
103	196		cervical cancer for uninsured and underinsured women. The report
104	197		shall may further recommend strategies or actions to reduce the
105	198		costs of breast and cervical cancer in the State of Oklahoma this
106	199		state.
107		-
108	200		D. The Advancement of Wellness Advisory Council shall evaluate
109	201		the prospective termination or continuation of its ongoing duties on
110	202		October 1, 2008. Such evaluation shall be made based on the
111	203		successful implementation of breast and cervical cancer reduction
112	204		plans and/or achievement of significant reductions in breast and
113	205		cervical cancer morbidity and mortality in the State of Oklahoma
114	206		this state.
115		-
116	207		SECTION 2. This act shall become effective October 1, 2021.
117	208
118		-
119		-	ENR. S. B. NO. 136 Page 4
120		-	Passed the Senate the 10th day of March, 2021.
121		-
122		-
123		-
124		-	Presiding Officer of the Senate
125		-
126		-
127		-	Passed the House of Represen tatives the 12th day of April, 2021.
128		-
129		-
130		-
131		-	Presiding Officer of the House
132		-	of Representatives
133		-
134		-	OFFICE OF THE GOVERNOR
135		-	Received by the Office of the Governor this _______ _____________
136		-	day of _______________ ____, 20_______, at _______ o'clock _______ M.
137		-	By: _______________________________ __
138		-	Approved by the Governor of the State of Oklahoma this _____ ____
139		-	day of _________________ __, 20_______, at _______ o'clock _______ M.
140		-
141		-	_________________________________
142		-	Governor of the State of Oklahoma
143		-
144		-
145		-	OFFICE OF THE SECRETARY OF STATE
146		-	Received by the Office of the Secretary of State this _______ ___
147		-	day of __________________, 20 _______, at _______ o'clock _______ M.
148		-	By: _______________________________ __
	209	+	COMMITTEE REPORT BY: COMM ITTEE ON PUBLIC HEALTH, dated 03/31/2021 -
	210	+	DO PASS.